John Matsoukas

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Concepts & Ideas

Chemicals & Drugs

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Katsara Maria; Deraos George; Tselios Theodore; Matsoukas Minos-Timotheos; Friligou Irene; Matsoukas John; Apostolopoulos Vasso
Design and synthesis of a cyclic double mutant peptide (cyclo(87-99)[A91,A96]MBP87-99) induces altered responses in mice after conjugation to mannan: implications in the immunotherapy of multiple sclerosis.
Sofianos Zacharias D; Katsila Theodora; Kostomitsopoulos Nikolaos; Balafas Vaggelis; Matsoukas John; Tselios Theodoros; Tamvakopoulos Constantin
In vivo evaluation and in vitro metabolism of leuprolide in mice--mass spectrometry-based biomarker measurement for efficacy and toxicity.
Katsara Maria; Yuriev Elizabeth; Ramsland Paul A; Deraos George; Tselios Theodore; Matsoukas John; Apostolopoulos Vasso
A double mutation of MBP(83-99) peptide induces IL-4 responses and antagonizes IFN-gamma responses.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of John Matsoukas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Katsara Maria; Deraos George; Tselios Theodore; Matsoukas Minos-Timotheos; Friligou Irene; Matsoukas John; Apostolopoulos Vasso
Design and synthesis of a cyclic double mutant peptide (cyclo(87-99)[A91,A96]MBP87-99) induces altered responses in mice after conjugation to mannan: implications in the immunotherapy of multiple sclerosis.
Journal of medicinal chemistry 2009;52(1):214-8.
2008: Sofianos Zacharias D; Katsila Theodora; Kostomitsopoulos Nikolaos; Balafas Vaggelis; Matsoukas John; Tselios Theodoros; Tamvakopoulos Constantin
In vivo evaluation and in vitro metabolism of leuprolide in mice--mass spectrometry-based biomarker measurement for efficacy and toxicity.
Journal of mass spectrometry : JMS 2008;43(10):1381-92.
2008: Katsara Maria; Yuriev Elizabeth; Ramsland Paul A; Deraos George; Tselios Theodore; Matsoukas John; Apostolopoulos Vasso
A double mutation of MBP(83-99) peptide induces IL-4 responses and antagonizes IFN-gamma responses.
Journal of neuroimmunology 2008;200(1-2):77-89.
2008: Katsara Maria; Yuriev Elizabeth; Ramsland Paul A; Deraos George; Tselios Theodore; Matsoukas John; Apostolopoulos Vasso
Mannosylation of mutated MBP83-99 peptides diverts immune responses from Th1 to Th2.
Molecular immunology 2008;45(13):3661-70.
2008: Katsara Maria; Matsoukas John; Deraos George; Apostolopoulos Vasso
Towards immunotherapeutic drugs and vaccines against multiple sclerosis.
Acta biochimica et biophysica Sinica 2008;40(7):636-42.
2008: Katsara Maria; Deraos George; Tselios Theodore; Matsoukas John; Apostolopoulos Vasso
Design of novel cyclic altered peptide ligands of myelin basic protein MBP83-99 that modulate immune responses in SJL/J mice.
Journal of medicinal chemistry 2008;51(13):3971-8.
2008: Mantzourani Efthimia D; Blokar Klemen; Tselios Theodore V; Matsoukas John M; Platts James A; Mavromoustakos Thomas M; Grdadolnik Simona Golic
A combined NMR and molecular dynamics simulation study to determine the conformational properties of agonists and antagonists against experimental autoimmune encephalomyelitis.
Bioorganic & medicinal chemistry 2008;16(5):2171-82.
2008: Tselios Theodore; Kelaidonis Konstantinos; Resvani Amalia; Prousalis Konstantinos; Matsoukas John; Tsegenidis Theodore
Solid phase synthesis of a glycopeptide analogue using the acid sensitive 4-methoxybenzhydryl bromide resin.
Protein and peptide letters 2008;15(1):1-5.
2007: Spyranti Zinovia; Dalkas Georgios A; Spyroulias Georgios A; Mantzourani Efthimia D; Mavromoustakos Thomas; Friligou Irene; Matsoukas John M; Tselios Theodore V
Putative bioactive conformations of amide linked cyclic myelin basic protein peptide analogues associated with experimental autoimmune encephalomyelitis.
Journal of medicinal chemistry 2007;50(24):6039-47.
2007: Flordellis C; Papathanasopoulos P; Lymperopoulos A; Matsoukas J; Paris H
Emerging therapeutic approaches multi-targeting receptor tyrosine kinases and g protein-coupled receptors in cardiovascular disease.
Cardiovascular & hematological agents in medicinal chemistry 2007;5(2):133-45.
2006: Mantzourani Efthimia D; Tselios Theodore V; Grdadolnik Simona Golic; Platts James A; Brancale Andrea; Deraos George N; Matsoukas John M; Mavromoustakos Thomas M
Comparison of proposed putative active conformations of myelin basic protein epitope 87-99 linear altered peptide ligands by spectroscopic and modelling studies: the role of positions 91 and 96 in T-cell receptor activation.
Journal of medicinal chemistry 2006;49(23):6683-91.
2006: Mantzourani E D; Tselios T V; Grdadolnik S Golic; Brancale A; Platts J A; Matsoukas J M; Mavromoustakos T M
A putative bioactive conformation for the altered peptide ligand of myelin basic protein and inhibitor of experimental autoimmune encephalomyelitis [Arg91, Ala96] MBP87-99.
Journal of molecular graphics & modelling 2006;25(1):17-29.
2006: Zoumpoulakis Panagiotis; Politi Aggeliki; Grdadolnik Simona Golic; Matsoukas John; Mavromoustakos Thomas
Structure elucidation and conformational study of V8: a novel synthetic non peptide AT(1) antagonist.
Journal of pharmaceutical and biomedical analysis 2006;40(5):1097-104.
2006: Keramida Maria K; Tselios Theodore; Mantzourani Efthimia; Papazisis Kostas; Mavromoustakos Thomas; Klaussen Christian; Agelis George; Deraos Spyros; Friligou Irene; Habibi Hamid; Matsoukas John
Design, synthesis, and molecular modeling of a novel amide-linked cyclic GnRH analogue cyclo(4-9)[Lys4,D-Trp6,Glu9]GnRH: stimulation of gonadotropin gene expression.
Journal of medicinal chemistry 2006;49(1):105-10.
2006: Katsara Maria; Tselios Theodore; Deraos Spyros; Deraos George; Matsoukas Minos-Timotheos; Lazoura Eliada; Matsoukas John; Apostolopoulos Vasso
Round and round we go: cyclic peptides in disease.
Current medicinal chemistry 2006;13(19):2221-32.
2005: Tselios Theodore V; Lamari Fotini N; Karathanasopoulou Ioanna; Katsara Maria; Apostolopoulos Vasso; Pietersz Geoffrey A; Matsoukas John M; Karamanos Nikos K
Synthesis and study of the electrophoretic behavior of mannan conjugates with cyclic peptide analogue of myelin basic protein using lysine-glycine linker.
Analytical biochemistry 2005;347(1):121-8.
2005: Matsoukas John; Apostolopoulos Vasso; Kalbacher Hubert; Papini Anna-Maria; Tselios Theodore; Chatzantoni Kokona; Biagioli Tiziana; Lolli Francesco; Deraos Spyros; Papathanassopoulos Panagiotis; Troganis Anastassios; Mantzourani Efthimia; Mavromoustakos Thomas; Mouzaki Athanasia
Design and synthesis of a novel potent myelin basic protein epitope 87-99 cyclic analogue: enhanced stability and biological properties of mimics render them a potentially new class of immunomodulators.
Journal of medicinal chemistry 2005;48(5):1470-80.
2005: Tzakos Andreas G; Troganis Anastassios; Theodorou Vassiliki; Tselios Theodore; Svarnas Christos; Matsoukas John; Apostolopoulos Vasso; Gerothanassis Ioannis P
Structure and function of the myelin proteins: current status and perspectives in relation to multiple sclerosis.
Current medicinal chemistry 2005;12(13):1569-87.
2005: Mantzourani E D; Mavromoustakos T M; Platts J A; Matsoukas J M; Tselios T V
Structural requirements for binding of myelin basic protein (MBP) peptides to MHC II: effects on immune regulation.
Current medicinal chemistry 2005;12(13):1521-35.
2005: Grigoriadis Nikolaos; Tselios Theodore; Deraos Spyros; Orologas Anastasios; Deraos George; Matsoukas John; Mavromatis Ioannis; Milonas Ioannis
Animal models of central nervous system immune-mediated diseases: therapeutic interventions with bioactive peptides and mimetics.
Current medicinal chemistry 2005;12(13):1513-9.
2004: Tzakos Andreas G; Fuchs Patrick; van Nuland Nico A J; Troganis Anastasios; Tselios Theodore; Deraos Spyros; Matsoukas John; Gerothanassis Ioannis P; Bonvin Alexandre M J J
NMR and molecular dynamics studies of an autoimmune myelin basic protein peptide and its antagonist: structural implications for the MHC II (I-Au)-peptide complex from docking calculations.
European journal of biochemistry / FEBS 2004;271(16):3399-413.
2004: Alexopoulos Kostas; Fatseas Panagiotis; Melissari Euthemia; Vlahakos Demetrios; Roumelioti Panagiota; Mavromoustakos Thomas; Mihailescu Stefan; Paredes-Carbajal Maria Christina; Mascher Dieter; Matsoukas John
Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
Journal of medicinal chemistry 2004;47(13):3338-52.
2004: Marathias K P; Agroyannis B; Mavromoustakos T; Matsoukas J; Vlahakos D V
Hematocrit-lowering effect following inactivation of renin-angiotensin system with angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
Current topics in medicinal chemistry 2004;4(4):483-6.
2004: Mavromoustakos T; Zervou M; Zoumpoulakis P; Kyrikou I; Benetis N P; Polevaya L; Roumelioti P; Giatas N; Zoga A; Minakakis P Moutevelis; Kolocouris A; Vlahakos D; Grdadolnik S Golic; Matsoukas J
Conformation and bioactivity. Design and discovery of novel antihypertensive drugs.
Current topics in medicinal chemistry 2004;4(4):385-401.
2003: Zoumpoulakis P; Zoga A; Roumelioti P; Giatas N; Grdadolnik S G; Iliodromitis E; Vlahakos D; Kremastinos D; Matsoukas J M; Mavromoustakos T
Conformational and biological studies for a pair of novel synthetic AT1 antagonists: stereoelectronic requirements for antihypertensive efficacy.
Journal of pharmaceutical and biomedical analysis 2003;31(5):833-44.
2002: Roumelioti Panagiota; Polevaya Ludmila; Zoumpoulakis Panagiotis; Giatas Nektarios; Mutule Ilze; Keivish Tatjana; Zoga Anastasia; Vlahakos Demetrios; Iliodromitis E; Kremastinos Demetrios; Grdadolnik Simona Golic; Mavromoustakos Thomas; Matsoukas John
Design, synthesis and biological evaluation of cyclic angiotensin II analogues with 3,5 side-chain bridges. Role of C-terminal aromatic residue and ring cluster for activity and implications in the drug design of AT1 non-peptide antagonists.
Bioorganic & medicinal chemistry letters 2002;12(18):2627-33.
2002: Zoumpoulakis Panagiotis; Grdadolnik Simona Golic; Matsoukas John; Mavromoustakos Thomas
Structure elucidation and conformational properties of eprosartan, a non peptide angiotensin II AT1 antagonist.
Journal of pharmaceutical and biomedical analysis 2002;28(1):125-35.
2002: Apostolopoulos V; Matsoukas J; Plebanski M; Mavromoustakos T
Applications of peptide mimetics in cancer.
Current medicinal chemistry 2002;9(4):411-20.
2002: Tselios Theodore; Apostolopoulos Vasso; Daliani Ioanna; Deraos Spyros; Grdadolnik Simona; Mavromoustakos Thomas; Melachrinou Maria; Thymianou Sotiria; Probert Lesley; Mouzaki Athanasia; Matsoukas John
Antagonistic effects of human cyclic MBP(87-99) altered peptide ligands in experimental allergic encephalomyelitis and human T-cell proliferation.
Journal of medicinal chemistry 2002;45(2):275-83.
2001: Matsoukas J; Apostolopoulos V; Mavromoustakos T
Designing peptide mimetics for the treatment of multiple sclerosis.
Mini reviews in medicinal chemistry 2001;1(3):273-82.
2001: Mavromoustakos T; Apostolopoulos V; Matsoukas J
Antihypertensive drugs that act on Renin-Angiotensin System with emphasis in AT(1) antagonists.
Mini reviews in medicinal chemistry 2001;1(2):207-17.
2001: Polevaya L; Mavromoustakos T; Zoumboulakis P; Golic Grdadolnik S; Roumelioti P; Giatas N; Mutule I; Keivish T; Vlahakos D V; Iliodromitis E K; Kremastinos D T; Matsoukas J
Synthesis and study of a cyclic angiotensin II antagonist analogue reveals the role of pi*--pi* interactions in the C-terminal aromatic residue for agonist activity and its structure resemblance with AT(1) non-peptide antagonists.
Bioorganic & medicinal chemistry 2001;9(6):1639-47.
2001: Alexopoulos K; Panagiotopoulos D; Mavromoustakos T; Fatseas P; Paredes-Carbajal M C; Mascher D; Mihailescu S; Matsoukas J
Design, synthesis, and modeling of novel cyclic thrombin receptor-derived peptide analogues of the Ser42-Phe-Leu-Leu-Arg46 motif sequence with fixed conformations of pharmacophoric groups: importance of a Phe/Arg/NH2 cluster for receptor activation and implications in the design of nonpeptide thrombin receptor mimetics.
Journal of medicinal chemistry 2001;44(3):328-39.
2001: Maragoudakis M E; Kraniti N; Giannopoulou E; Alexopoulos K; Matsoukas J
Modulation of angiogenesis and progelatinase a by thrombin receptor mimetics and antagonists.
Endothelium : journal of endothelial cell research 2001;8(3):195-205.
2000: Tselios T; Daliani I; Deraos S; Thymianou S; Matsoukas E; Troganis A; Gerothanassis I; Mouzaki A; Mavromoustakos T; Probert L; Matsoukas J
Treatment of experimental allergic encephalomyelitis (EAE) by a rationally designed cyclic analogue of myelin basic protein (MBP) epitope 72-85.
Bioorganic & medicinal chemistry letters 2000;10(24):2713-7.
2000: Tselios T; Daliani I; Probert L; Deraos S; Matsoukas E; Roy S; Pires J; Moore G; Matsoukas J
Treatment of experimental allergic encephalomyelitis (EAE) induced by guinea pig myelin basic protein epitope 72-85 with a human MBP(87-99) analogue and effects of cyclic peptides.
Bioorganic & medicinal chemistry 2000;8(8):1903-9.
2000: Roumelioti P; Tselios T; Alexopoulos K; Mavromoustakos T; Kolocouris A; Moore G J; Matsoukas J M
Structural comparison between type I and type II antagonists: possible implications in the drug design of AT1 antagonists.
Bioorganic & medicinal chemistry letters 2000;10(8):755-8.
2000: Matsoukas J M; Polevaya L; Ancans J; Mavromoustakos T; Kolocouris A; Roumelioti P; Vlahakos D V; Yamdagni R; Wu Q; Moore G J
The design and synthesis of a potent Angiotensin II cyclic analogue confirms the ring cluster receptor conformation of the hormone Angiotensin II.
Bioorganic & medicinal chemistry 2000;8(1):1-10.
1999: Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Smith J; Mavromoustakos T; Saifeddine M; Moore G; Hollenberg M; Matsoukas J
Design and synthesis of thrombin receptor-derived nonpeptide mimetics utilizing a piperazine scaffold.
Bioorganic & medicinal chemistry 1999;7(6):1033-41.
1999: Mavromoustakos T; Kolocouris A; Zervou M; Roumelioti P; Matsoukas J; Weisemann R
An effort to understand the molecular basis of hypertension through the study of conformational analysis of losartan and sarmesin using a combination of nuclear magnetic resonance spectroscopy and theoretical calculations.
Journal of medicinal chemistry 1999;42(10):1714-22.
1999: Tselios T; Probert L; Daliani I; Matsoukas E; Troganis A; Gerothanassis I P; Mavromoustakos T; Moore G J; Matsoukas J M
Design and synthesis of a potent cyclic analogue of the myelin basic protein epitope MBP72-85: importance of the Ala81 carboxyl group and of a cyclic conformation for induction of experimental allergic encephalomyelitis.
Journal of medicinal chemistry 1999;42(7):1170-7.
1998: Mavromoustakos T; Zervou M; Panagiotopoulos D; Theodoropoulou E; Matsoukas J; Karussis D
Structural elucidation and conformational properties of the immunomodulator linomide.
Journal of pharmaceutical and biomedical analysis 1998;16(5):741-51.
1998: Alexopoulos K; Matsoukas J; Tselios T; Roumelioti P; Mavromoustakos T; Holada K
A comparative SAR study of thrombin receptor derived non peptide mimetics: importance of phenyl/guanidino proximity for activity.
Amino acids 1998;15(3):211-20.
1998: Tselios T; Probert L; Kollias G; Matsoukas E; Roumelioti P; Alexopoulos K; Moore G J; Matsoukas J
Design and synthesis of small semi-mimetic peptides with immunomodulatory activity based on myelin basic protein (MBP).
Amino acids 1998;14(4):333-41.
1998: Pires J M; Matsoukas J M; Moore G J
Recognition of the encephalitogenic myelin basic protein (74-85) peptide by the immune system: importance of conformation.
Proceedings of the Western Pharmacology Society 1998;41():193-5.
1997: Matsoukas J; Hollenberg M D; Mavromoustakos T; Panagiotopoulos D; Alexopoulos K; Yamdagni R; Wu Q; Moore G J
Conformational analysis of the thrombin receptor agonist peptides SFLLR and SFLLR-NH2 by NMR: evidence for a cyclic bioactive conformation.
Journal of protein chemistry 1997;16(2):113-31.
1996: Matsoukas J M; Panagiotopoulos D; Keramida M; Mavromoustakos T; Yamdagni R; Wu Q; Moore G J; Saifeddine M; Hollenberg M D
Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: importance of the Phe/Arg relative conformation and the primary amino group for activity.
Journal of medicinal chemistry 1996;39(18):3585-91.
1995: Matsoukas J M; Agelis G; Wahhab A; Hondrelis J; Panagiotopoulos D; Yamdagni R; Wu Q; Mavromoustakos T; Maia H L; Ganter R
Differences in backbone structure between angiotensin II agonists and type I antagonists.
Journal of medicinal chemistry 1995;38(23):4660-9.
1995: Moore G J; Smith J R; Baylis B W; Matsoukas J M
Design and pharmacology of peptide mimetics.
Advances in pharmacology (San Diego, Calif.) 1995;33():91-41.
1994: Moore G J; Ganter R C; Matsoukas J M; Hondrelis J; Agelis G; Barlos K; Wilkinson S; Sandall J; Fowler P
Receptor interactions of the position 4 side chains of angiotensin II analogues: importance of aromatic ring quadrupole.
Journal of molecular recognition : JMR 1994;7(4):251-6.
1994: Matsoukas J M; Hondrelis J; Agelis G; Barlos K; Gatos D; Ganter R; Moore D; Moore G J
Novel synthesis of cyclic amide-linked analogues of angiotensins II and III.
Journal of medicinal chemistry 1994;37(18):2958-69.
1994: Matsoukas J M; Hondrelis J; Keramida M; Mavromoustakos T; Makriyannis A; Yamdagni R; Wu Q; Moore G J
Role of the NH2-terminal domain of angiotensin II (ANG II) and [Sar1]angiotensin II on conformation and activity. NMR evidence for aromatic ring clustering and peptide backbone folding compared with [des-1,2,3]angiotensin II.
The Journal of biological chemistry 1994;269(7):5303-12.
1993: Wahhab A; Smith J R; Ganter R C; Moore D M; Hondrelis J; Matsoukas J; Moore G J
Imidazole based non-peptide angiotensin II receptor antagonists. Investigation of the effect of the orientation of the imidazole ring on biological activity.
Arzneimittel-Forschung 1993;43(11):1157-68.
1993: Matsoukas J M; Agelis G; Hondrelis J; Yamdagni R; Wu Q; Ganter R; Smith J R; Moore D; Moore G J
Synthesis and biological activities of angiotensin II, Sarilesin, and Sarmesin analogues containing Aze or Pip at position 7.
Journal of medicinal chemistry 1993;36(7):904-11.
1992: Lonergan G; Routsi E; Georgiadis T; Agelis G; Hondrelis J; Matsoukas J; Larsen L K; Caplan F R
Isolation, NMR studies, and biological activities of onopordopicrin from Centaurea sonchifolia.
Journal of natural products 1992;55(2):225-8.
1992: Gikas M; Agelis G; Matsoukas J; Moore G J; Dupont L; Englebert S
Structure of N-tert-butoxycarbonyl-L-phenylalanine benzyl ester.
Acta crystallographica. Section C, Crystal structure communications 1992;48 ( Pt 1)():216-7.
1991: Turner R J; Matsoukas J M; Moore G J
Fluorescence properties of angiotensin II analogues in receptor-simulating environments: relationship between tyrosinate fluorescence lifetime and biological activity.
Biochimica et biophysica acta 1991;1065(1):21-8.
1991: Hondrelis J; Matsoukas J; Cordopatis P; Ganter R C; Franklin K J; Moore G J
Synthesis and biological activities of angiotensin II and Sarmesin analogues containing cyclohexylalanine.
International journal of peptide and protein research 1991;37(1):21-6.
1990: Turner R J; Matsoukas J M; Moore G J
Tyrosinate fluorescence lifetimes for oxytocin and vasopressin in receptor-simulating environments: relationship to biological activity and 1H-NMR data.
Biochemical and biophysical research communications 1990;171(3):996-1001.
1990: Matsoukas J M; Yamdagni R; Moore G J
1H-NMR studies of sarmesin and [des1]sarmesin conformation in dimethylsulfoxide by nuclear Overhauser effect (NOE) enhancement spectroscopy: folding of the N- and C-terminal domains.
Peptides 1990;11(2):367-74.
1990: Matsoukas J M; Bigam G; Zhou N; Moore G J
1H-NMR studies of [Sar1]angiotensin II conformation by nuclear Overhauser effect spectroscopy in the rotating frame (ROESY): clustering of the aromatic rings in dimethylsulfoxide.
Peptides 1990;11(2):359-66.
1989: Lonergan G; Psachoulia C; Marmaras V; Hondrelis J; Sanida C; Matsoukas J
Isolation and identification of free amino acids as crystalline N-t-butyloxycarbonyl, O-phenacyl derivatives.
Analytical biochemistry 1989;176(2):368-72.
1988: Matsoukas J; Cordopatis P; Belte U; Goghari M H; Ganter R C; Franklin K J; Moore G J
Importance of the N-terminal domain of the type II angiotensin antagonist sarmesin for receptor blockade.
Journal of medicinal chemistry 1988;31(7):1418-21.
1985: Matsoukas J M; Goghari M H; Scanlon M N; Franklin K J; Moore G J
Synthesis and biological activities of analogues of angiotensins II and III containing O-methyltyrosine and D-tryptophan.
Journal of medicinal chemistry 1985;28(6):780-3.
1984: Matsoukas J M; Scanlon M N; Moore G J
A cyclic angiotensin antagonist: [1,8-cysteine]angiotensin II.
Journal of medicinal chemistry 1984;27(3):404-6.
1984: Scanlon M N; Matsoukas J M; Franklin K J; Moore G J
A new approach to angiotensin antagonists: methylation of the tyrosine hydroxyl in angiotensin II.
Life sciences 1984;34(4):317-21.
1984: Moore G J; Matsoukas J M; Scanlon M N; Franklin K J; Goghari M H
On the mechanisms of action of two classes of angiotensin antagonists at smooth muscle receptors.
Proceedings of the Western Pharmacology Society 1984;27():377-83.
1983: Cordopatis P; Matsoukas J; Michel A; Janen J; Theodoropoulos D
Synthesis and biological activities of [beta-Malyl1]- and [beta-Malyl1, Leu8]-angiotensin II analogues.
Experientia 1983;39(4):353-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

John Matsoukas

Research Profile (preview)

Concepts & Ideas

Chemicals & Drugs

Phenomena

Living Beings

Occupations

Physiology

Genes & Molecular Sequences

Disorders

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of John Matsoukas (preview)

All Publications